The establishment of the crucial role of circ_0057558/miR-206/ROCK1/AMPK pathway in lipogenesis shed light on molecular mechanisms underlying NAFLD development and progression, and thus provides alternative avenues for NAFLD therapy. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.